These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23607551)

  • 1. In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells.
    Zimonjic DB; Chan LN; Tripathi V; Lu J; Kwon O; Popescu NC; Lowy DR; Tamanoi F
    BMC Cancer; 2013 Apr; 13():198. PubMed ID: 23607551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo antitumor effect of a novel inhibitor of protein geranylgeranyltransferase-I.
    Lu J; Chan L; Fiji HD; Dahl R; Kwon O; Tamanoi F
    Mol Cancer Ther; 2009 May; 8(5):1218-26. PubMed ID: 19417142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoformulation of Geranylgeranyltransferase-I Inhibitors for Cancer Therapy: Liposomal Encapsulation and pH-Dependent Delivery to Cancer Cells.
    Lu J; Yoshimura K; Goto K; Lee C; Hamura K; Kwon O; Tamanoi F
    PLoS One; 2015; 10(9):e0137595. PubMed ID: 26352258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of mechanism of action of P61-E7, a novel phosphine catalysis-based inhibitor of geranylgeranyltransferase-I.
    Chan LN; Fiji HD; Watanabe M; Kwon O; Tamanoi F
    PLoS One; 2011; 6(10):e26135. PubMed ID: 22028818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of RhoA and RalB in geranylgeranyltransferase I inhibitor-mediated inhibition of proliferation and migration of human oral squamous cell carcinoma cells.
    Hamada M; Miki T; Iwai S; Shimizu H; Yura Y
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):559-69. PubMed ID: 21107573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of geranylgeranyltransferase inhibits bronchial smooth muscle hyperresponsiveness in mice.
    Chiba Y; Sato S; Hanazaki M; Sakai H; Misawa M
    Am J Physiol Lung Cell Mol Physiol; 2009 Nov; 297(5):L984-91. PubMed ID: 19717551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
    Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
    Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of protein geranylgeranyltransferase I and Rab geranylgeranyltransferase identified from a library of allenoate-derived compounds.
    Watanabe M; Fiji HD; Guo L; Chan L; Kinderman SS; Slamon DJ; Kwon O; Tamanoi F
    J Biol Chem; 2008 Apr; 283(15):9571-9. PubMed ID: 18230616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSAT1 regulates cyclin D1 degradation and sustains proliferation of non-small cell lung cancer cells.
    Yang Y; Wu J; Cai J; He Z; Yuan J; Zhu X; Li Y; Li M; Guan H
    Int J Cancer; 2015 Feb; 136(4):E39-50. PubMed ID: 25142862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of cancer cell invasion by a geranylgeranyltransferase-I inhibitor.
    Kusama T; Mukai M; Tatsuta M; Matsumoto Y; Nakamura H; Inoue M
    Clin Exp Metastasis; 2003; 20(6):561-7. PubMed ID: 14598891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The geranylgeranyltransferase-I inhibitor GGTI-298 arrests human tumor cells in G0/G1 and induces p21(WAF1/CIP1/SDI1) in a p53-independent manner.
    Vogt A; Sun J; Qian Y; Hamilton AD; Sebti SM
    J Biol Chem; 1997 Oct; 272(43):27224-9. PubMed ID: 9341167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel histone deacetylase inhibitor exhibits antitumor activity via apoptosis induction, F-actin disruption and gene acetylation in lung cancer.
    Tang YA; Wen WL; Chang JW; Wei TT; Tan YH; Salunke S; Chen CT; Chen CS; Wang YC
    PLoS One; 2010 Sep; 5(9):e12417. PubMed ID: 20856855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells.
    Lee HY; Moon H; Chun KH; Chang YS; Hassan K; Ji L; Lotan R; Khuri FR; Hong WK
    J Natl Cancer Inst; 2004 Oct; 96(20):1536-48. PubMed ID: 15494604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens.
    Wu YY; Wu HC; Wu JE; Huang KY; Yang SC; Chen SX; Tsao CJ; Hsu KF; Chen YL; Hong TM
    J Exp Clin Cancer Res; 2019 Jul; 38(1):282. PubMed ID: 31262325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis.
    Watts KL; Cottrell E; Hoban PR; Spiteri MA
    Respir Res; 2006 Jun; 7(1):88. PubMed ID: 16776827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geranylgeranyl transferase 1 inhibitor GGTI‑298 enhances the anticancer effect of gefitinib.
    Liu BS; Dai XY; Xia HW; Xu HJ; Tang QL; Gong QY; Nie YZ; Bi F
    Mol Med Rep; 2018 Oct; 18(4):4023-4029. PubMed ID: 30106149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.
    Falsetti SC; Wang DA; Peng H; Carrico D; Cox AD; Der CJ; Hamilton AD; Sebti SM
    Mol Cell Biol; 2007 Nov; 27(22):8003-14. PubMed ID: 17875936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumor growth and metastasis by non-small cell lung cancer cells transfected with cyclin D1-targeted siRNA.
    Huang H; Hu YD; Li N; Zhu Y
    Oligonucleotides; 2009 Jun; 19(2):151-62. PubMed ID: 19355812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.
    Li YL; Wang J; Zhang CY; Shen YQ; Wang HM; Ding L; Gu YC; Lou JT; Zhao XT; Ma ZL; Jin YX
    Oncotarget; 2016 Sep; 7(37):59287-59298. PubMed ID: 27494902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo.
    Singh T; Prasad R; Katiyar SK
    Epigenetics; 2013 Jan; 8(1):54-65. PubMed ID: 23221619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.